PEAR Annual Cash & Cash Equivalents
$48.30 M
-$121.27 M-71.52%
31 December 2022
Summary:
As of February 1, 2025, PEAR annual cash & cash equivalents is $48.30 million, with the most recent change of -$121.27 million (-71.52%) on December 31, 2022. During the last 3 years, it has risen by +$20.89 million (+76.18%).PEAR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Quarterly Cash And Cash Equivalents
$48.30 M
-$11.38 M-19.07%
31 December 2022
Summary:
As of February 1, 2025, PEAR quarterly cash and cash equivalents is $48.30 million, with the most recent change of -$11.38 million (-19.07%) on December 31, 2022. Over the past year, it has dropped by -$121.27 million (-71.52%).PEAR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.5% | -71.5% |
| 3 y3 years | +76.2% | - |
| 5 y5 years | +76.2% | - |
PEAR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -71.5% | -71.5% |
Pear Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $48.30 M(-71.5%) | $48.30 M(-19.1%) |
| Sept 2022 | - | $59.69 M(-0.8%) |
| June 2022 | - | $60.19 M(-32.7%) |
| Mar 2022 | - | $89.43 M(-47.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $169.57 M(+52.9%) | $169.57 M(+171.6%) |
| Sept 2021 | - | $62.44 M(-32.3%) |
| June 2021 | - | $92.22 M(-16.8%) |
| Dec 2020 | $110.90 M(+304.5%) | $110.90 M |
| Dec 2019 | $27.41 M | - |
FAQ
- What is Pear Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pear Therapeutics?
- What is Pear Therapeutics annual cash & cash equivalents year-on-year change?
- What is Pear Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pear Therapeutics?
- What is Pear Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Pear Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PEAR is $48.30 M
What is the all time high annual cash & cash equivalents for Pear Therapeutics?
Pear Therapeutics all-time high annual cash & cash equivalents is $169.57 M
What is Pear Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, PEAR annual cash & cash equivalents has changed by -$121.27 M (-71.52%)
What is Pear Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PEAR is $48.30 M
What is the all time high quarterly cash and cash equivalents for Pear Therapeutics?
Pear Therapeutics all-time high quarterly cash and cash equivalents is $169.57 M
What is Pear Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PEAR quarterly cash and cash equivalents has changed by -$121.27 M (-71.52%)